EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Research-Evidence-Practice Gaps in Post-stroke Neuro-recovery Pharmacological Therapies in Asia

Hou Chang Chiu, Yangchen Yangchen, Dayangku Siti Nur Ashikin Pengiran Tengah, Navuth Na Chum, Yapeng Lin, Wing-Chi Fong, Vijaya Pamidimukkala, Jeyaraj Durai Pandian, Girianto Tjandrawidjaja, Shinichiro Uchiyama, Mi-Sun Oh, Saysavath Keosodsay und 14 weitere

Cerebrovascular Diseases Extra · 29.07.2026 · 1-14

DOI: 10.1159/000553635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases Extra, online erschienen am 29.07.2026. Verfasst von Hou Chang Chiu und 25 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our recently-published systematic-search-and-review identified eight registered treatments with level A or B-R evidence of improving neuro-recovery after a stroke. In this study, we aimed to assess their availability, usage, and recommendation in national guidelines in different Asian countries or regions.

Methods

We conducted a survey on availability, estimated usage in stroke patients, inclusion in local stroke guidelines, and if they believed more clinical trials were necessary for nimodipine, edaravone, cinepazide, clomethiazole, selective-serotonin reuptake inhibitors (SSRIs), MLC601/MLC901, cerebrolysin and panax notoginseng among leading neurologists from 21 countries or regions in Asia.

Results

Nimodipine and SSRIs are the most widely available across countries or regions in Asia. National stroke guidelines uniformly recommend nimodipine for SAH, while SSRIs are indicated and used for post-stroke depression. Edaravone, MLC601/ MLC901, cerebrolysin and panax notoginseng are available in about a third to half of the countries or regions surveyed, while cinepazide and clomethiazole are generally unavailable. Even when available, usage is low particularly when not in the national guidelines. Further clinical trials are often desired on treatments that are not widely available or in the guidelines.

Conclusion

We found research-evidence-practice gaps in several post-stroke treatments for neuro-recovery, particularly in terms of availability and inclusion in clinical guidelines. Bridging the gap between research and practice will be crucial to improve patient outcome.

Zitieren

APA

Chiu, H. C., Yangchen, Y., Pengiran Tengah, D. S. N. A., Chum, N. N., Lin, Y., Fong, W. C., Pamidimukkala, V., Pandian, J. D., Tjandrawidjaja, G., Uchiyama, S., Oh, M. S., Keosodsay, S., Tan, K. S., Ravdan, A., Lay, P. P., Thapa, L., Siddiqui, M., Navarro, J. C., Chang, H. M., …, & Venketasubramanian, N. (2026). Research-Evidence-Practice Gaps in Post-stroke Neuro-recovery Pharmacological Therapies in Asia. Cerebrovascular Diseases Extra, 1-14. https://doi.org/10.1159/000553635

Vancouver

Chiu HC, Yangchen Y, Pengiran Tengah DSNA, Chum NN, Lin Y, Fong WC, et al. Research-Evidence-Practice Gaps in Post-stroke Neuro-recovery Pharmacological Therapies in Asia. Cerebrovascular Diseases Extra. 2026:1-14. doi:10.1159/000553635

BibTeX
@article{Chiu2026,
  author = {Chiu, Hou Chang and Yangchen, Yangchen and Pengiran Tengah, Dayangku Siti Nur Ashikin and Chum, Navuth Na and Lin, Yapeng and Fong, Wing-Chi and Pamidimukkala, Vijaya and Pandian, Jeyaraj Durai and Tjandrawidjaja, Girianto and Uchiyama, Shinichiro and Oh, Mi-Sun and Keosodsay, Saysavath and Tan, Kay Sin and Ravdan, Amarbayasgalan and Lay, Phyu Phyu and Thapa, Lekhjung and Siddiqui, Maimoona and Navarro, Jose C and Chang, Hui Meng and Ranawaka, Udaya K and Lee, Tsong-Hai and Chan, Lung and Roongpiboonsopit, Duangnapa and Suwanwela, Nijasri C and Nguyen, Thang Huy and Venketasubramanian, Narayanaswamy},
  title = {Research-Evidence-Practice Gaps in Post-stroke Neuro-recovery Pharmacological Therapies in Asia},
  journal = {Cerebrovascular Diseases Extra},
  year = {2026},
  pages = {1--14},
  doi = {10.1159/000553635}
}
Kostenlos starten →